BARDINI, MICHELA
 Distribuzione geografica
Continente #
NA - Nord America 3.621
EU - Europa 2.131
AS - Asia 1.774
SA - Sud America 314
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.870
Nazione #
US - Stati Uniti d'America 3.538
SG - Singapore 624
IT - Italia 565
CN - Cina 559
RU - Federazione Russa 296
HK - Hong Kong 277
DE - Germania 258
SE - Svezia 237
BR - Brasile 235
IE - Irlanda 225
UA - Ucraina 139
VN - Vietnam 130
GB - Regno Unito 102
ES - Italia 59
CA - Canada 58
FI - Finlandia 54
AT - Austria 41
IN - India 37
FR - Francia 34
NL - Olanda 32
EC - Ecuador 30
ID - Indonesia 26
KR - Corea 24
AR - Argentina 19
DK - Danimarca 18
BD - Bangladesh 17
BE - Belgio 17
MX - Messico 17
PL - Polonia 17
TR - Turchia 14
JP - Giappone 13
ZA - Sudafrica 13
IQ - Iraq 10
PT - Portogallo 10
PY - Paraguay 7
CO - Colombia 6
LT - Lituania 6
PE - Perù 6
TW - Taiwan 6
VE - Venezuela 6
CH - Svizzera 5
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
GR - Grecia 4
IR - Iran 4
RO - Romania 4
CL - Cile 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
KE - Kenya 3
NO - Norvegia 3
PK - Pakistan 3
TN - Tunisia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
EU - Europa 2
GD - Grenada 2
IL - Israele 2
PH - Filippine 2
SA - Arabia Saudita 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 7.870
Città #
Ann Arbor 469
Ashburn 375
Singapore 348
Hong Kong 273
Chandler 246
Fairfield 244
Dublin 223
Woodbridge 209
Houston 206
Frankfurt am Main 156
Wilmington 147
Milan 133
Jacksonville 132
New York 116
Beijing 102
Dearborn 94
Seattle 89
Cambridge 74
Santa Clara 67
Princeton 61
Los Angeles 58
Dallas 55
Hefei 55
Nanjing 52
Ho Chi Minh City 45
Vienna 35
Moscow 34
Shanghai 31
São Paulo 30
The Dalles 30
Rome 28
Lawrence 27
Barcelona 23
Hanoi 23
Chicago 22
Buffalo 21
Guangzhou 21
Lachine 21
Seoul 21
Jakarta 19
Munich 19
San Diego 19
Altamura 18
Andover 17
Shenyang 17
Brooklyn 16
London 16
Nanchang 15
Warsaw 15
Brussels 14
Chennai 14
Fremont 14
Orem 14
Phoenix 14
Tianjin 14
Denver 13
Helsinki 13
Naples 13
Stockholm 13
Hangzhou 12
Quito 12
Bari 11
Dong Ket 11
Guayaquil 11
Manchester 11
Nuremberg 11
Rio de Janeiro 11
Turku 11
Boston 10
Johannesburg 10
Lissone 10
Norwalk 10
Poplar 10
Jinan 9
Montreal 9
Allentown 8
Changsha 8
Columbus 8
Perugia 8
Salt Lake City 8
Hebei 7
Huizen 7
Lappeenranta 7
Philadelphia 7
Tokyo 7
Ankara 6
Boardman 6
Brasília 6
Council Bluffs 6
Düsseldorf 6
Edmonton 6
Falls Church 6
Florence 6
Kunming 6
Taipei 6
Toronto 6
Zhengzhou 6
Belo Horizonte 5
Bergamo 5
Cagliari 5
Totale 5.034
Nome #
Infant ALL with MLL-AF4 is sustained by t(4;11) as the sole genetic abnormality, and it is initiated in mice by phenotypically and functionally distinct leukemic stem cell subsets 485
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 352
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 340
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 317
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 307
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL 290
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLL-r B-ALL by regulating NR3C1 expression 284
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 264
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 255
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement 238
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients 234
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 229
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 227
Effects of C/EBPalpha and C/EBPbeta in BCR/ABL-Expressing Cells: Differences and Similarities 218
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency 209
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 207
In Infant ALL with t(4;11)/MLL-AF4 Multiple and Phenotypically Distinct CD19+ BM Subsets Initiate Leukemia in NOD/SCID Mice 194
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 191
Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients 190
The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia 182
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 181
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 171
Correction to: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (Leukemia, (2018), 32, 3, (633-644), 10.1038/leu.2017.294) 169
Expression of CCL9/MIP-1bold italic gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells 165
Generazione di modelli in vivo per l'identificazione e lo studio di clonalità delle cellule staminali leucemiche nella LAL infant MLL-AF4 positiva 165
LAL infant introduces a new specific genomic profile 165
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 164
Identification and characterization of candidate L-ICs IN MLL-AF4 infant all 161
Unique genomic profile of infant all patients 161
In infant all with t(4;11)/mll-af4 multiple and phenotypically distinct bm subsets initiate leukemia into nod/scid mice 160
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 159
Oligoclonal origin of functionally distinct leukemic stem cells in infant acute lymphoblastic leukemia 154
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease 148
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia 147
Inducible activation of C/EBPb, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells 144
Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment is dependent on Stearoyl CoA desaturase 143
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia 132
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients 111
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome 70
Totale 8.083
Categoria #
all - tutte 25.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021348 0 0 0 0 0 53 71 50 30 51 46 47
2021/2022441 33 35 35 30 42 68 14 24 19 46 20 75
2022/2023920 86 275 86 74 51 155 14 55 76 1 35 12
2023/2024660 26 30 41 35 75 178 122 31 44 14 20 44
2024/20251.480 79 120 65 90 93 39 110 35 172 266 141 270
2025/20262.006 438 195 311 468 430 164 0 0 0 0 0 0
Totale 8.083